OticPharma is a clinical-stage pharmaceutical company focusing on the acquisition and development of ear, nose, and throat (ENT) products that restore health and address unmet needs in children and adults. The company's proprietary foam technology (OP-01) is currently being developed for acute otitis externa ("swimmers ear") and is also being explored for the treatment of nasal and sinus conditions. The company's proprietary surfactant technology (OP-02) is currently being developed as a potential first-in-class, antibiotic-free treatment option for acute, recurrent, and chronic otitis media.
View Top Employees from OticPharma, Inc.| Website | http://www.oticpharma.com |
| Revenue | $8 million |
| Employees | View employees |
| Founded | 2008 |
| Address | 19900 MacArthur Blvd., Ste. 550, Irvine, California 92612, US |
| Phone | (949) 238-8090 |
| Technologies | |
| Industry | Pharmaceuticals, Biotechnology, Clinical Trials, Health Care, Healthcare, Pharmaceutical, Therapeutics |
| Competitors | Aclaris Therapeutics, Inc., Brickell Biotech, Inc., Chiesi USA, Inc., CymaBay Therapeutics, MediQuest Therapeutics, Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular OticPharma, Inc. employee's phone or email?
OticPharma, Inc. Questions
The OticPharma, Inc. annual revenue was $8 million in 2024.
OticPharma, Inc. is based in Irvine, California.
The NAICS codes for OticPharma, Inc. are [32, 3254, 325].
The SIC codes for OticPharma, Inc. are [283, 28].
Related Companies
